Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (r)-n,n-diisopropyl-3-(2-hydroxy-5-hydroxymethylphenyl)-3-phenylpropanamine
2. 5-hydroxymethyl Tolterodine
3. Pnu 200577
4. Pnu-200577
1. 207679-81-0
2. (r)-5-hydroxymethyl Tolterodine
3. 5-hydroxymethyl Tolterodine
4. (r)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol
5. Pnu-200577
6. 5-hydroxymethyltolterodine
7. Desfesoterodine [inn]
8. 5-hmt
9. Pnu 200577
10. 3-[(1r)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxybenzenemethanol
11. 5-hydroxymethyl Tolterodine (pnu 200577, 5-hmt, 5-hm)
12. Spm 7605
13. Yu871o78gr
14. (+)-n,n-diisopropyl-3-(2-hydroxy-5-hydroxymethylphenyl)-3-phenylpropylamine
15. 207679-81-0 (free Base)
16. Benzenemethanol, 3-[(1r)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxy-
17. Desfesoterodine (inn)
18. (r)-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenol
19. Benzenemethanol, 3-((1r)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-hydroxy-
20. 2-[(1r)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenol
21. Unii-yu871o78gr
22. Desfesoterodin
23. R-5-hydroxymethyl Tolterodine
24. 5-hm
25. (r)-2-[3-(diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenol
26. 5-hydroxymethyl-tolterodine
27. Intermediate Of Fesoterodine
28. Schembl209062
29. (r)-5-hydroxymethyltolterodine
30. Zinc6047
31. Chembl3348932
32. Desfesoterodine [who-dd]
33. Dtxsid40431319
34. Chebi:177454
35. Dd 01
36. Hms3884p12
37. Bcp02922
38. Spm-7605
39. Mfcd09264524
40. Pnu200577
41. S2659
42. Akos005146249
43. Akos015841720
44. Ccg-267936
45. Cs-0825
46. Db15578
47. Ncgc00346585-01
48. Ac-23943
49. Bs-15813
50. Hy-76569
51. Bcp0726000296
52. 5-hydroxymethyl Tolterodine (pnu 200577)
53. 5-hydroxymethyl Tolterodine - Pnu 200577
54. Sw219846-1
55. D10853
56. F31141
57. 264h524
58. J-013606
59. Q27294711
60. (r)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxy Methyl Phenol
61. (r)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxy Methylphenol
62. (r)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenol
63. (r)-4-hydroxymethyl-2-(3-diisopropylamino-1-phenylpropyl)-phenol
| Molecular Weight | 341.5 g/mol |
|---|---|
| Molecular Formula | C22H31NO2 |
| XLogP3 | 4.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 8 |
| Exact Mass | 341.235479232 g/mol |
| Monoisotopic Mass | 341.235479232 g/mol |
| Topological Polar Surface Area | 43.7 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 357 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
G - Genito urinary system and sex hormones
G04 - Urologicals
G04B - Urologicals
G04BD - Drugs for urinary frequency and incontinence
G04BD13 - Desfesoterodine
5-Hydroxymethyl tolterodine is a known human metabolite of tolterodine.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ANALYTICAL
ABOUT THIS PAGE
A Desfesoterodine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Desfesoterodine, including repackagers and relabelers. The FDA regulates Desfesoterodine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Desfesoterodine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Desfesoterodine supplier is an individual or a company that provides Desfesoterodine active pharmaceutical ingredient (API) or Desfesoterodine finished formulations upon request. The Desfesoterodine suppliers may include Desfesoterodine API manufacturers, exporters, distributors and traders.
click here to find a list of Desfesoterodine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Desfesoterodine DMF (Drug Master File) is a document detailing the whole manufacturing process of Desfesoterodine active pharmaceutical ingredient (API) in detail. Different forms of Desfesoterodine DMFs exist exist since differing nations have different regulations, such as Desfesoterodine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Desfesoterodine DMF submitted to regulatory agencies in the US is known as a USDMF. Desfesoterodine USDMF includes data on Desfesoterodine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Desfesoterodine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Desfesoterodine suppliers with USDMF on PharmaCompass.
A Desfesoterodine written confirmation (Desfesoterodine WC) is an official document issued by a regulatory agency to a Desfesoterodine manufacturer, verifying that the manufacturing facility of a Desfesoterodine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Desfesoterodine APIs or Desfesoterodine finished pharmaceutical products to another nation, regulatory agencies frequently require a Desfesoterodine WC (written confirmation) as part of the regulatory process.
click here to find a list of Desfesoterodine suppliers with Written Confirmation (WC) on PharmaCompass.
Desfesoterodine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Desfesoterodine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Desfesoterodine GMP manufacturer or Desfesoterodine GMP API supplier for your needs.
A Desfesoterodine CoA (Certificate of Analysis) is a formal document that attests to Desfesoterodine's compliance with Desfesoterodine specifications and serves as a tool for batch-level quality control.
Desfesoterodine CoA mostly includes findings from lab analyses of a specific batch. For each Desfesoterodine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Desfesoterodine may be tested according to a variety of international standards, such as European Pharmacopoeia (Desfesoterodine EP), Desfesoterodine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Desfesoterodine USP).
LOOKING FOR A SUPPLIER?
